Literature DB >> 8021242

An amino acid sequence shared by the herpes simplex virus 1 alpha regulatory proteins 0, 4, 22, and 27 predicts the nucleotidylylation of the UL21, UL31, UL47, and UL49 gene products.

J A Blaho1, C Mitchell, B Roizman.   

Abstract

Earlier reports showed that at least 3 herpes simplex virus 1 proteins were adenylylated and guanylylated in addition to the infected cell proteins (ICPs) 0, 4, 22, and 27. ICP22 and 27 share the amino acid sequence R/PRAP/SR which is also predicted to be in ICPs 4 and 0 and in the products of the HSV-1 genes UL21, UL31, UL47, and UL49. ICPs 0, 4, 22, and 27 are regulatory proteins, UL21 is dispensable for growth in cultured cells, UL31 co-fractionates with the nuclear matrix, and UL47 may interact stoichiometrically with the alpha trans-inducing factor (VP16, the product of the UL48 gene). To avoid bias, the genes encoding the additional nucleotidylylated proteins were mapped, initially by analyses of intertypic recombinant viruses, and subsequently by analyses of the products encoded by the mapped genome domains. We conclude that (i) the products of UL21, UL31, UL47, and UL49 are nucleotidylylated by [alpha-32P]GTP or [alpha-32P]ATP in isolated nuclei, (ii) this modification does not involve the viral protein kinases encoded by the UL13 and US3 gene products and, (iii) UL49 is a virion protein which is labeled in cells with [32P]orthophosphate and also is ADP-ribosylated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021242

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Requirements for the nuclear-cytoplasmic translocation of infected-cell protein 0 of herpes simplex virus 1.

Authors:  P Lopez; C Van Sant; B Roizman
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

2.  Nuclear localization and shuttling of herpes simplex virus tegument protein VP13/14.

Authors:  M Donnelly; G Elliott
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  Functional anatomy of herpes simplex virus 1 overlapping genes encoding infected-cell protein 22 and US1.5 protein.

Authors:  W O Ogle; B Roizman
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  Herpes simplex virus type 1 ICP0 protein does not accumulate in the nucleus of primary neurons in culture.

Authors:  X p Chen; J Li; M Mata; J Goss; D Wolfe; J C Glorioso; D J Fink
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

5.  Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus.

Authors:  Yasuyuki Gomi; Hiroki Sunamachi; Yasuko Mori; Kazuhiro Nagaike; Michiaki Takahashi; Koichi Yamanishi
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

6.  Assembly of infectious Herpes simplex virus type 1 virions in the absence of full-length VP22.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

7.  Ultrastructural localization of the herpes simplex virus type 1 UL31, UL34, and US3 proteins suggests specific roles in primary envelopment and egress of nucleocapsids.

Authors:  Ashley E Reynolds; Elizabeth G Wills; Richard J Roller; Brent J Ryckman; Joel D Baines
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 8.  Role of ICP0 in the strategy of conquest of the host cell by herpes simplex virus 1.

Authors:  Ryan Hagglund; Bernard Roizman
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Identification and characterization of the pseudorabies virus tegument proteins UL46 and UL47: role for UL47 in virion morphogenesis in the cytoplasm.

Authors:  Martina Kopp; Barbara G Klupp; Harald Granzow; Walter Fuchs; Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Temporal regulation of herpes simplex virus type 2 VP22 expression and phosphorylation.

Authors:  B J Geiss; J E Tavis; L M Metzger; D A Leib; L A Morrison
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.